|
Volumn 90, Issue 5, 2010, Pages 521-522
|
Valsartan-induced drug eruption followed by CD30+pseudolymphomatous eruption
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
BETAMETHASONE BUTYRATE PROPIONATE;
BETAMETHASONE DERIVATIVE;
CD30 ANTIGEN;
PREDNISOLONE;
UNCLASSIFIED DRUG;
VALSARTAN;
AGED;
CASE REPORT;
CLINICAL EVALUATION;
DERMIS;
DRUG ERUPTION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
ERYTHEMA;
HUMAN;
HYPERTENSION;
IMMUNOHISTOCHEMISTRY;
LETTER;
LYMPHOCYTIC INFILTRATION;
MALE;
NARROW BAND IMAGING;
PATIENT REFERRAL;
PRIORITY JOURNAL;
PRURITUS;
PSEUDOLYMPHOMA;
SKIN BIOPSY;
TREATMENT DURATION;
ULTRAVIOLET B RADIATION;
AGED, 80 AND OVER;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANTI-INFLAMMATORY AGENTS;
ANTIGENS, CD30;
ANTIHYPERTENSIVE AGENTS;
BETAMETHASONE;
BIOPSY;
COMBINED MODALITY THERAPY;
DRUG ERUPTIONS;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MALE;
PREDNISOLONE;
PSEUDOLYMPHOMA;
SKIN;
TETRAZOLES;
TREATMENT OUTCOME;
ULTRAVIOLET THERAPY;
VALINE;
|
EID: 77957661009
PISSN: 00015555
EISSN: None
Source Type: Journal
DOI: 10.2340/00015555-0695 Document Type: Letter |
Times cited : (23)
|
References (6)
|